167 related articles for article (PubMed ID: 20979539)
1. Intrafollicular and serum levels of leptin during in vitro fertilization cycles: comparison between the effects of recombinant follicle-stimulating hormones and human menopausal gonadotrophin.
Almog B; Azem F; Kapustiansky R; Azolai J; Wagman I; Levin I; Hauser R; Pauzner D; Lessing JB; Amit A; Gamzu R
Gynecol Endocrinol; 2011 Sep; 27(9):666-8. PubMed ID: 20979539
[TBL] [Abstract][Full Text] [Related]
2. Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone.
Foong SC; Abbott DH; Lesnick TG; Session DR; Walker DL; Dumesic DA
Fertil Steril; 2005 May; 83(5):1377-83. PubMed ID: 15866572
[TBL] [Abstract][Full Text] [Related]
3. Is recombinant follicle-stimulating hormone more effective in IVF poor responders than human menopausal gonadotrophins?
Eskandar M; Jaroudi K; Jambi A; Archibong EI; Coskun S; Sobande AA
Med Sci Monit; 2004 Jan; 10(1):PI6-9. PubMed ID: 14704644
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
Kovacs P; Kovats T; Bernard A; Zadori J; Szmatona G; Kaali SG
Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing their first treatment cycle of IVF or ICSI.
Bjercke S; Tanbo T; Abyholm T; Omland A; Opøien HK; Fedorcsak P
Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1053-60. PubMed ID: 20602599
[TBL] [Abstract][Full Text] [Related]
6. The relation of serum and follicular fluid leptin and ovarian steroid levels in response to induction of ovulation in in vitro fertilization cycles.
Gürbüz B; Yalti S; Ficicioglu C; Taşdemir S
Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):214-8. PubMed ID: 15653206
[TBL] [Abstract][Full Text] [Related]
7. Leptin, VEGF, IGF-1, and IGFBP-3 concentrations in serum and follicular fluid of women undergoing in vitro fertilization.
Dorn C; Reinsberg J; Kupka M; van der Ven H; Schild RL
Arch Gynecol Obstet; 2003 Aug; 268(3):187-93. PubMed ID: 12942249
[TBL] [Abstract][Full Text] [Related]
8. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
[TBL] [Abstract][Full Text] [Related]
9. Circulating level of macrophage colony-stimulating factor can be predictive for human in vitro fertilization outcome.
Salmassi A; Mettler L; Jonat W; Buck S; Koch K; Schmutzler AG
Fertil Steril; 2010 Jan; 93(1):116-23. PubMed ID: 18996518
[TBL] [Abstract][Full Text] [Related]
10. Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome?
Ocal P; Aydin S; Cepni I; Idil S; Idil M; Uzun H; Benian A
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):194-9. PubMed ID: 15262355
[TBL] [Abstract][Full Text] [Related]
11. Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial.
Ye H; Huang G; Pei L; Zeng P; Luo X
Gynecol Endocrinol; 2012 Jul; 28(7):540-4. PubMed ID: 22390186
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged < 37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study.
Gholami H; Vicari E; Molis M; La Vignera S; Papaleo E; Cappiello F
Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):97-102. PubMed ID: 20329567
[TBL] [Abstract][Full Text] [Related]
13. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
[TBL] [Abstract][Full Text] [Related]
14. [The clinical significance of the ratio in FSH/LH of human menopausal gonadotropins in a programmed stimulation regimen for IVF-ET].
Ikenaga H
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Nov; 47(11):1223-9. PubMed ID: 8543846
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
[TBL] [Abstract][Full Text] [Related]
16. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
Mashiach R; Amit A; Hasson J; Amzalzg S; Almog B; Ben-Yosef D; Lessing JB; Limor R; Azem F
Fertil Steril; 2010 May; 93(7):2299-302. PubMed ID: 19261276
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
[TBL] [Abstract][Full Text] [Related]
18. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
19. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG.
Gomes MK; Vieira CS; Moura MD; Manetta LA; Leite SP; Reis RM; Ferriani RA
Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):99-106. PubMed ID: 16835006
[TBL] [Abstract][Full Text] [Related]
20. Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial.
Lee VC; Chan CC; Ng EH; Yeung WS; Ho PC
Reprod Biomed Online; 2011 Sep; 23(3):380-8. PubMed ID: 21782514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
